Navigation Links
China Sky One Medical, Inc. Featured by Science and Technology Daily

HARBIN, China, Jan. 19 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it has been featured by 'Science and Technology Daily,' an authoritative and influential publication in China covering science, technology, and innovation.

The 8,000-word long article in 'Science and Technology Daily' chronicles China Sky One Medical's 15-year history as it went from being a small distributor of medicines in China to a leading developer and producer of high quality pharmaceuticals listed on the NASDAQ Global Select Market. From the author's perspective, the Company's strong research and development capabilities have given it an edge over thousands of medicine manufacturers in China. From the very beginning, China Sky One Medical made a decision to invest significantly in research and development, which has turned out to be a core competency for the Company.

The article reported that China Sky One Medical's bio-engineering medical laboratory and Traditional Chinese Medicine (TCM) laboratory are both considered key provincial laboratories. China Sky One Medical is now developing several cancer diagnostic kits through its Heilongjiang Research Center for Bio-engineering Diagnostic Products. In addition, the Company has built long-term cooperative relationships with Harbin Medical University and many other research institutions.

"We are delighted that 'Science and Technology Daily' decided to profile China Sky One in this way so that our innovative approach and portfolio of pharmaceutical products can benefit more and more people," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "Going forward, we will continue to focus our efforts in developing more new proprietary medical products to create value for both customers and shareholders."

To view the full article in Chinese, please click on: .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include expectations of future growth or information regarding the move to new headquarters. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-0451-8703-2617

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:    +1-646-213-1915

     Mr. R. Micchelli, Sr. Financial Writer
     Tel:   +1-646-454-4516

SOURCE China Sky One Medical, Inc.



SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Significant urban-rural disparities in injury mortality seen in China
2. China a rising star in regenerative medicine despite world skepticism of stem cell therapies
3. China Nepstar Chain Drugstore Announces Change to the Board
4. China rapidly catching up in research impact
5. CordLife Secures Strategic Presence in China
6. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
7. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
8. Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China
9. ESC to give talks on diabetes in 3 cities in China
10. China Medical Technologies Reports Second Fiscal Quarter Financial Results
11. China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
Post Your Comments:
(Date:11/30/2015)... ... , ... According to an article published November 13th by People ... to show her Instagram followers that the praise that they were bestowing on her ... she didn’t “want to mislead any mommy's who just had babies and are stressing,” ...
(Date:11/30/2015)... ... ... A record crowd gathered at the Pennsylvania Biotech Center of Bucks County ... Institute. , The institute, which is the research arm of the Hepatitis B Foundation, ... conference, which focused on ways companies can work to reduce the cost and improve ...
(Date:11/30/2015)... ... November 30, 2015 , ... At Grand Dental PC, their ... setting. , When you have dental problems, you need to turn to a dentist ... diagnose and treat your needs, a friendly dentist who counsels you on the best ...
(Date:11/30/2015)... ... , ... Newly reviewed and approved “NJ Top Dentist”, Dr. Eugene Isola III, ... Medicine in 1935. His father graduated from NYU School of Dentistry in 1965. ... as their commitment and passion to the Practice of Dentistry. Continuing the family ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation ... cancer education and prevention—is joining forces with the award-winning creator and writer of ... on December 7, 2015 at the Union League of Philadelphia. , The ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic pain, ... at the U.S. Patent and Trademark Office (USPTO) has denied ... Patent No. 8,359,102 (the ,102 patent).  ... unit of Boston Scientific Corporation filed two petitions challenging the ...
(Date:11/30/2015)... , Nov. 30, 2015 ... the "Orphan Drugs Market 2015-2019" report ... has announced the addition of the "Orphan ... --> Research and Markets ( ... "Orphan Drugs Market 2015-2019" report to their ...
(Date:11/30/2015)... global cell culture market is expected ... bn by 2022 at a CAGR of 7.1% therein. --> ... its 2013 value of US$6.1 bn to US$11.3 bn by 2022 ... Research has announced the release of a new market research study, ... ,Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends ...
Breaking Medicine Technology: